• Josephine Lai, Frank Porreca, John C Hunter, and Michael S Gold.
• Departments of Pharmacology, University of Arizona Health Sciences Center, Tucson, Arizona 85724, USA. lai@u.arizona.edu
• Annu. Rev. Pharmacol. Toxicol. 2004 Jan 1;44:371-97.

AbstractPhysiological and pharmacological evidence both have demonstrated a critical role for voltage-gated sodium channels (VGSCs) in many types of chronic pain syndromes because these channels play a fundamental role in the excitability of neurons in the central and peripheral nervous systems. Alterations in function of these channels appear to be intimately linked to hyperexcitability of neurons. Many types of pain appear to reflect neuronal hyperexcitability, and importantly, use-dependent sodium channel blockers are effective in the treatment of many types of chronic pain. This review focuses on the role of VGSCs in the hyperexcitability of sensory primary afferent neurons and their contribution to the inflammatory or neuropathic pain states. The discrete localization of the tetrodotoxin (TTX)-resistant channels, in particular NaV1.8, in the peripheral nerves may provide a novel opportunity for the development of a drug targeted at these channels to achieve efficacious pain relief with an acceptable safety profile.

33 keywords...

hide…